<p>Adlai Nortye Ltd. 贊助的 ADR (NASDAQ:ANL - 獲取免費報告) 的股價在週三下跌了 11.7%。該股最低交易價為 $7.20，最後交易價為 $13.8410。在午盤交易中，共交易了 967,940 股，較平均交易量 596,093 股增加了 62%。該股之前的收盤價為 $15.68。</p>
<h2>分析師評級調整</h2>
<p>幾家券商最近對 ANL 進行了評估。Weiss Ratings 在 1 月 21 日的研究報告中重申了對 Adlai Nortye 的 &#34;賣出 (e+)&#34; 評級。HC Wainwright 將 Adlai Nortye 的評級從 &#34;中性&#34; 上調至 &#34;買入&#34;，並在 2 月 13 日的研究報告中設定了 $16.00 的目標價。Leerink Partners 於 3 月 20 日開始對 Adlai Nortye 進行覆蓋。他們對該股給予了 &#34;跑贏大盤&#34; 的評級，並設定了 $23.00 的目標價。最後，Wall Street Zen 在 3 月 7 日的研究報告中將 Adlai Nortye 的評級上調至 &#34;持有&#34;。兩位研究分析師給予該股 &#34;買入&#34; 評級，一位給予 &#34;賣出&#34; 評級。根據 MarketBeat.com 的數據，Adlai Nortye 目前的共識評級為 &#34;持有&#34;，平均目標價為 $19.50。</p>
<p><strong>查看我們關於 Adlai Nortye 的最新研究報告</strong></p>
<h2>Adlai Nortye 價格表現</h2>
<p>該公司的 50 日簡單移動平均線為 $9.03，200 日簡單移動平均線為 $4.44。</p>
<h2>關於 Adlai Nortye</h2>
<p>(獲取免費報告)</p>
<p>Adlai Nortye Inc NASDAQ: ANL 是一家總部位於中國江蘇省的特種化學品製造商。該公司專注於精細化學品的研究、開發、生產和銷售，主要強調氨基酸及其衍生物。</p>
<p>Adlai Nortye 的產品組合包括甜菜鹼化合物、一系列高純度的 L-氨基酸，如 L-蛋氨酸、L-蘇氨酸和甘氨酸，以及各種化學中間體。這些產品服務於多個終端市場，包括動物飼料和營養、個人護理和化妝品配方、藥用成分和工業化學過程。</p>
<p>該公司在多個生產設施中運營，並設有專門致力於工藝創新和質量控制的內部研發中心。</p>
<h2>瞭解更多</h2>
<ul>
<li>五隻我們更看好的股票，勝過 Adlai Nortye</li>
</ul>
<p><em>此即時新聞提醒由敍述科學技術和 MarketBeat 的金融數據生成，以便為讀者提供最快的報道和公正的覆蓋。請將任何問題或意見發送至 contact@marketbeat.com。</em></p>
<h2>你現在應該投資 $1,000 在 Adlai Nortye 嗎？</h2>
<p>在你考慮 Adlai Nortye 之前，你需要聽聽這個。</p>
<p>MarketBeat 每天跟蹤華爾街頂級評級和表現最佳的研究分析師及其推薦給客户的股票。MarketBeat 已識別出五隻頂級分析師悄悄向客户推薦的股票，建議在更廣泛的市場注意到之前購買……而 Adlai Nortye 並不在名單上。</p>
<p>雖然 Adlai Nortye 目前在分析師中獲得了 &#34;持有&#34; 評級，但頂級分析師認為這五隻股票更值得購買。</p>
<p>在這裏查看這五隻股票</p>

醫藥突破 ETF - ALPS

基因改革 ETF - ARK

<p>Adlai Nortye (NASDAQ:ANL) 的股價下跌了 11.7%，至 13.84 美元，交易量增加了 62%，達到 967,940 股。分析師們的意見不一：Weiss Ratings 維持 “賣出” 評級，而 HC Wainwright 將其評級上調至 “買入”，目標價為 16 美元。Leerink Partners 給予 “跑贏大盤” 評級，目標價為 23 美元。目前，市場共識評級為 “持有”，平均目標價為 19.50 美元。Adlai Nortye 專注於精細化學品，特別是氨基酸及其衍生物，服務於包括動物飼料和製藥在內的多個市場</p>

<p>Adlai Nortye Ltd. Sponsored ADR (NASDAQ:ANL - Get Free Report)'s stock price fell 11.7% on Wednesday . The stock traded as low as $7.20 and last traded at $13.8410. 967,940 shares were traded during mid-day trading, an increase of 62% from the average session volume of 596,093 shares. The stock had previously closed at $15.68.</p>
<div class="lb-trans"><p>Adlai Nortye Ltd. 贊助的 ADR (NASDAQ:ANL - 獲取免費報告) 的股價在週三下跌了 11.7%。該股最低交易價為 $7.20，最後交易價為 $13.8410。在午盤交易中，共交易了 967,940 股，較平均交易量 596,093 股增加了 62%。該股之前的收盤價為 $15.68。</p>
</div><h2>Analyst Upgrades and Downgrades</h2>
<div class="lb-trans"><h2>分析師評級調整</h2>
</div><p>Several brokerages recently weighed in on ANL. Weiss Ratings reiterated a &#34;sell (e+)&#34; rating on shares of Adlai Nortye in a research report on Wednesday, January 21st. HC Wainwright upgraded shares of Adlai Nortye from a &#34;neutral&#34; rating to a &#34;buy&#34; rating and set a $16.00 price objective on the stock in a research report on Friday, February 13th. Leerink Partners began coverage on shares of Adlai Nortye in a research report on Friday, March 20th. They issued an &#34;outperform&#34; rating and a $23.00 price objective on the stock. Finally, Wall Street Zen upgraded shares of Adlai Nortye to a &#34;hold&#34; rating in a research report on Saturday, March 7th. Two research analysts have rated the stock with a Buy rating and one has given a Sell rating to the stock. According to MarketBeat.com, Adlai Nortye currently has a consensus rating of &#34;Hold&#34; and an average price target of $19.50.</p>
<div class="lb-trans"><p>幾家券商最近對 ANL 進行了評估。Weiss Ratings 在 1 月 21 日的研究報告中重申了對 Adlai Nortye 的 &#34;賣出 (e+)&#34; 評級。HC Wainwright 將 Adlai Nortye 的評級從 &#34;中性&#34; 上調至 &#34;買入&#34;，並在 2 月 13 日的研究報告中設定了 $16.00 的目標價。Leerink Partners 於 3 月 20 日開始對 Adlai Nortye 進行覆蓋。他們對該股給予了 &#34;跑贏大盤&#34; 的評級，並設定了 $23.00 的目標價。最後，Wall Street Zen 在 3 月 7 日的研究報告中將 Adlai Nortye 的評級上調至 &#34;持有&#34;。兩位研究分析師給予該股 &#34;買入&#34; 評級，一位給予 &#34;賣出&#34; 評級。根據 MarketBeat.com 的數據，Adlai Nortye 目前的共識評級為 &#34;持有&#34;，平均目標價為 $19.50。</p>
</div><p><strong>View Our Latest Research Report on Adlai Nortye</strong></p>
<div class="lb-trans"><p><strong>查看我們關於 Adlai Nortye 的最新研究報告</strong></p>
</div><h2>Adlai Nortye Price Performance</h2>
<div class="lb-trans"><h2>Adlai Nortye 價格表現</h2>
</div><p>The firm's 50-day simple moving average is $9.03 and its 200 day simple moving average is $4.44.</p>
<div class="lb-trans"><p>該公司的 50 日簡單移動平均線為 $9.03，200 日簡單移動平均線為 $4.44。</p>
</div><h2>About Adlai Nortye</h2>
<div class="lb-trans"><h2>關於 Adlai Nortye</h2>
</div><p>(Get Free Report)</p>
<div class="lb-trans"><p>(獲取免費報告)</p>
</div><p>Adlai Nortye Inc NASDAQ: ANL is a specialty chemical manufacturer headquartered in China’s Jiangsu Province. The company focuses on the research, development, production and sale of fine chemicals, with a primary emphasis on amino acids and their derivatives.</p>
<div class="lb-trans"><p>Adlai Nortye Inc NASDAQ: ANL 是一家總部位於中國江蘇省的特種化學品製造商。該公司專注於精細化學品的研究、開發、生產和銷售，主要強調氨基酸及其衍生物。</p>
</div><p>Adlai Nortye’s product portfolio includes betaine compounds, a range of high-purity L-amino acids such as L-methionine, L-threonine and glycine, as well as various chemical intermediates. These offerings serve multiple end markets, including animal feed and nutrition, personal care and cosmetic formulations, pharmaceutical ingredients and industrial chemical processes.</p>
<div class="lb-trans"><p>Adlai Nortye 的產品組合包括甜菜鹼化合物、一系列高純度的 L-氨基酸，如 L-蛋氨酸、L-蘇氨酸和甘氨酸，以及各種化學中間體。這些產品服務於多個終端市場，包括動物飼料和營養、個人護理和化妝品配方、藥用成分和工業化學過程。</p>
</div><p>The company operates multiple production facilities alongside an in-house research and development center dedicated to process innovation and quality control.</p>
<div class="lb-trans"><p>該公司在多個生產設施中運營，並設有專門致力於工藝創新和質量控制的內部研發中心。</p>
</div><h2>Read More</h2>
<div class="lb-trans"><h2>瞭解更多</h2>
</div><ul>
<li>Five stocks we like better than Adlai Nortye</li>
</ul>
<div class="lb-trans"><ul>
<li>五隻我們更看好的股票，勝過 Adlai Nortye</li>
</ul>
</div><p><em>This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.</em></p>
<div class="lb-trans"><p><em>此即時新聞提醒由敍述科學技術和 MarketBeat 的金融數據生成，以便為讀者提供最快的報道和公正的覆蓋。請將任何問題或意見發送至 contact@marketbeat.com。</em></p>
</div><h2>Should You Invest $1,000 in Adlai Nortye Right Now?</h2>
<div class="lb-trans"><h2>你現在應該投資 $1,000 在 Adlai Nortye 嗎？</h2>
</div><p>Before you consider Adlai Nortye, you'll want to hear this.</p>
<div class="lb-trans"><p>在你考慮 Adlai Nortye 之前，你需要聽聽這個。</p>
</div><p>MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Adlai Nortye wasn't on the list.</p>
<div class="lb-trans"><p>MarketBeat 每天跟蹤華爾街頂級評級和表現最佳的研究分析師及其推薦給客户的股票。MarketBeat 已識別出五隻頂級分析師悄悄向客户推薦的股票，建議在更廣泛的市場注意到之前購買……而 Adlai Nortye 並不在名單上。</p>
</div><p>While Adlai Nortye currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.</p>
<div class="lb-trans"><p>雖然 Adlai Nortye 目前在分析師中獲得了 &#34;持有&#34; 評級，但頂級分析師認為這五隻股票更值得購買。</p>
</div><p>View The Five Stocks Here</p>
<div class="lb-trans"><p>在這裏查看這五隻股票</p>
</div>

Adlai Nortye (NASDAQ:ANL) 股價下跌 11.7% - 事件回顧